R. Bilous

The Lancet · 2003–2019

A researcher in the Science corpus: 4 papers; trusts 0 researchers and is trusted by 2 researchers here, as inferred from the citation graph.

Whom R. Bilous trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Nathan
  2. B. Zinman
  3. I. D. de Boer

Who trusts R. Bilous overall

  1. Nur Samsu
  2. Christine L. Ferguson

Papers from R. Bilous's perspective

Ordered by how strongly the researchers R. Bilous trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Glucose control and vascular complications in veterans with type 2 diabetes. (New England Journal of Medicine)
  2. Effects of Intensive Glucose Lowering in Type 2 Diabetes
  3. Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. (The Lancet)
  4. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. (New England Journal of Medicine)
  5. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial
  6. Renal and Retinal Effects of Enalapril and Losartan in Type 1 Diabetes (New England Journal of Medicine)
  7. Modern-Day Clinical Course of Type 1 Diabetes Mellitus After 30 Years’ Duration (Archives of Internal Medicine)
  8. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study (British medical journal)
  9. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. (New England Journal of Medicine)
  10. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. (New England Journal of Medicine)

Their papers